333 related articles for article (PubMed ID: 29774544)
1. Functional molecules in mesothelial-to-mesenchymal transition revealed by transcriptome analyses.
Namvar S; Woolf AS; Zeef LA; Wilm T; Wilm B; Herrick SE
J Pathol; 2018 Aug; 245(4):491-501. PubMed ID: 29774544
[TBL] [Abstract][Full Text] [Related]
2. MiR-200a negatively regulates TGF-β
Guo R; Hao G; Bao Y; Xiao J; Zhan X; Shi X; Luo L; Zhou J; Chen Q; Wei X
Am J Physiol Renal Physiol; 2018 Jun; 314(6):F1087-F1095. PubMed ID: 29357421
[TBL] [Abstract][Full Text] [Related]
3. Caveolin1 and YAP drive mechanically induced mesothelial to mesenchymal transition and fibrosis.
Strippoli R; Sandoval P; Moreno-Vicente R; Rossi L; Battistelli C; Terri M; Pascual-Antón L; Loureiro M; Matteini F; Calvo E; Jiménez-Heffernan JA; Gómez MJ; Jiménez-Jiménez V; Sánchez-Cabo F; Vázquez J; Tripodi M; López-Cabrera M; Del Pozo MÁ
Cell Death Dis; 2020 Aug; 11(8):647. PubMed ID: 32811813
[TBL] [Abstract][Full Text] [Related]
4. Asiaticoside inhibits TGF-β1-induced mesothelial-mesenchymal transition and oxidative stress via the Nrf2/HO-1 signaling pathway in the human peritoneal mesothelial cell line HMrSV5.
Zhao J; Shi J; Shan Y; Yu M; Zhu X; Zhu Y; Liu L; Sheng M
Cell Mol Biol Lett; 2020; 25():33. PubMed ID: 32514269
[TBL] [Abstract][Full Text] [Related]
5. MicroRNA-302c modulates peritoneal dialysis-associated fibrosis by targeting connective tissue growth factor.
Li X; Liu H; Sun L; Zhou X; Yuan X; Chen Y; Liu F; Liu Y; Xiao L
J Cell Mol Med; 2019 Apr; 23(4):2372-2383. PubMed ID: 30693641
[TBL] [Abstract][Full Text] [Related]
6. Genetic or pharmacologic blockade of enhancer of zeste homolog 2 inhibits the progression of peritoneal fibrosis.
Shi Y; Tao M; Wang Y; Zang X; Ma X; Qiu A; Zhuang S; Liu N
J Pathol; 2020 Jan; 250(1):79-94. PubMed ID: 31579944
[TBL] [Abstract][Full Text] [Related]
7. MiR-29b may suppresses peritoneal metastases through inhibition of the mesothelial-mesenchymal transition (MMT) of human peritoneal mesothelial cells.
Kimura Y; Ohzawa H; Miyato H; Kaneko Y; Saito A; Takahashi K; Tojo M; Yamaguchi H; Kurashina K; Saito S; Hosoya Y; Lefor AK; Sata N; Kitayama J
Sci Rep; 2022 Jan; 12(1):205. PubMed ID: 34997082
[TBL] [Abstract][Full Text] [Related]
8. Blockade of thrombospondin-1 ameliorates high glucose-induced peritoneal fibrosis through downregulation of TGF-β1/Smad3 signaling pathway.
Jiang N; Zhang Z; Shao X; Jing R; Wang C; Fang W; Mou S; Ni Z
J Cell Physiol; 2020 Jan; 235(1):364-379. PubMed ID: 31236971
[TBL] [Abstract][Full Text] [Related]
9. A pathogenetic role for endothelin-1 in peritoneal dialysis-associated fibrosis.
Busnadiego O; Loureiro-Álvarez J; Sandoval P; Lagares D; Dotor J; Pérez-Lozano ML; López-Armada MJ; Lamas S; López-Cabrera M; Rodríguez-Pascual F
J Am Soc Nephrol; 2015 Jan; 26(1):173-82. PubMed ID: 25012164
[TBL] [Abstract][Full Text] [Related]
10. Blocking TGF-β1 protects the peritoneal membrane from dialysate-induced damage.
Loureiro J; Aguilera A; Selgas R; Sandoval P; Albar-Vizcaíno P; Pérez-Lozano ML; Ruiz-Carpio V; Majano PL; Lamas S; Rodríguez-Pascual F; Borras-Cuesta F; Dotor J; López-Cabrera M
J Am Soc Nephrol; 2011 Sep; 22(9):1682-95. PubMed ID: 21742730
[TBL] [Abstract][Full Text] [Related]
11. Gremlin promotes peritoneal membrane injury in an experimental mouse model and is associated with increased solute transport in peritoneal dialysis patients.
Siddique I; Curran SP; Ghayur A; Liu L; Shi W; Hoff CM; Gangji AS; Brimble KS; Margetts PJ
Am J Pathol; 2014 Nov; 184(11):2976-84. PubMed ID: 25194662
[TBL] [Abstract][Full Text] [Related]
12. Reprogramming of Mesothelial-Mesenchymal Transition in Chronic Peritoneal Diseases by Estrogen Receptor Modulation and TGF-β1 Inhibition.
Wilson RB; Archid R; Reymond MA
Int J Mol Sci; 2020 Jun; 21(11):. PubMed ID: 32532126
[TBL] [Abstract][Full Text] [Related]
13. Effects of TGF-β1 Receptor Inhibitor GW788388 on the Epithelial to Mesenchymal Transition of Peritoneal Mesothelial Cells.
Lho Y; Do JY; Heo JY; Kim AY; Kim SW; Kang SH
Int J Mol Sci; 2021 Apr; 22(9):. PubMed ID: 33947038
[TBL] [Abstract][Full Text] [Related]
14. Nitro-oleic acid inhibits the high glucose-induced epithelial-mesenchymal transition in peritoneal mesothelial cells and attenuates peritoneal fibrosis.
Su W; Wang H; Feng Z; Sun J
Am J Physiol Renal Physiol; 2020 Feb; 318(2):F457-F467. PubMed ID: 31760768
[TBL] [Abstract][Full Text] [Related]
15. Mesothelial-to-mesenchymal transition as a possible therapeutic target in peritoneal metastasis of ovarian cancer.
Rynne-Vidal A; Au-Yeung CL; Jiménez-Heffernan JA; Pérez-Lozano ML; Cremades-Jimeno L; Bárcena C; Cristóbal-García I; Fernández-Chacón C; Yeung TL; Mok SC; Sandoval P; López-Cabrera M
J Pathol; 2017 Jun; 242(2):140-151. PubMed ID: 28247413
[TBL] [Abstract][Full Text] [Related]
16. Inhibition of hyperglycolysis in mesothelial cells prevents peritoneal fibrosis.
Si M; Wang Q; Li Y; Lin H; Luo D; Zhao W; Dou X; Liu J; Zhang H; Huang Y; Lou T; Hu Z; Peng H
Sci Transl Med; 2019 Jun; 11(495):. PubMed ID: 31167927
[TBL] [Abstract][Full Text] [Related]
17. WNT signaling is required for peritoneal membrane angiogenesis.
Padwal M; Cheng G; Liu L; Boivin F; Gangji AS; Brimble KS; Bridgewater D; Margetts PJ
Am J Physiol Renal Physiol; 2018 Jun; 314(6):F1036-F1045. PubMed ID: 29363326
[TBL] [Abstract][Full Text] [Related]
18. Connective tissue growth factor (CTGF/CCN2) is increased in peritoneal dialysis patients with high peritoneal solute transport rate.
Mizutani M; Ito Y; Mizuno M; Nishimura H; Suzuki Y; Hattori R; Matsukawa Y; Imai M; Oliver N; Goldschmeding R; Aten J; Krediet RT; Yuzawa Y; Matsuo S
Am J Physiol Renal Physiol; 2010 Mar; 298(3):F721-33. PubMed ID: 20015945
[TBL] [Abstract][Full Text] [Related]
19. Tamoxifen ameliorates peritoneal membrane damage by blocking mesothelial to mesenchymal transition in peritoneal dialysis.
Loureiro J; Sandoval P; del Peso G; Gónzalez-Mateo G; Fernández-Millara V; Santamaria B; Bajo MA; Sánchez-Tomero JA; Guerra-Azcona G; Selgas R; López-Cabrera M; Aguilera AI
PLoS One; 2013; 8(4):e61165. PubMed ID: 23637793
[TBL] [Abstract][Full Text] [Related]
20. Pathobiological mechanisms of peritoneal adhesions: The mesenchymal transition of rat peritoneal mesothelial cells induced by TGF-β1 and IL-6 requires activation of Erk1/2 and Smad2 linker region phosphorylation.
Jin X; Ren S; Macarak E; Rosenbloom J
Matrix Biol; 2016 Apr; 51():55-64. PubMed ID: 26825317
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]